Compile Data Set for Download or QSAR
Report error Found 1003 for UniProtKB: Q9WMX2
TargetGenome polyprotein [810-3010](HCV)
Janssen Ireland

US Patent
LigandPNGBDBM243442(US9427428, 1)
Affinity DataEC50:  0.0580nMAssay Description:In a transient set-up, a Huh-7 lunet hepatoma cell line was transiently transfected with an autonomously replicating RNA encoding a bi-cistronic expr...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240838(US9394331, 135 | US9394331, 32)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240839(US9394331, 138 | US9394331, 50)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240840(US9394331, 36)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240841(US9394331, 139 | US9394331, 51)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240842(US9394331, 44)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240843(US9394331, 137 | US9394331, 49)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240844(US9394331, 136 | US9394331, 48)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240845(US9394331, 140 | US9394331, 52)
Affinity DataEC50: >5.45E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240846(US9394331, 62)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240847(US9394331, 72)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240848(US9394331, 76)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240849(US9394331, 77)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240850(US9394331, 66)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240851(US9394331, 114)
Affinity DataEC50:  2.06E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240852(US9394331, 115)
Affinity DataEC50:  2.85E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240853(US9394331, 116)
Affinity DataEC50:  2.83E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240854(US9394331, 117)
Affinity DataEC50:  1.67E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240855(US9394331, 113)
Affinity DataEC50:  1.55E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240856(US9394331, 119 | US9394331, 118)
Affinity DataEC50:  1.49E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240856(US9394331, 119 | US9394331, 118)
Affinity DataEC50:  4.52E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240858(US9394331, 121 | US9394331, 120)
Affinity DataEC50:  390nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240858(US9394331, 121 | US9394331, 120)
Affinity DataEC50:  9.31E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240860(US9394331, 122)
Affinity DataEC50:  857nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240861(US9394331, 123)
Affinity DataEC50:  310nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240862(US9394331, 124)
Affinity DataEC50:  566nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240863(US9394331, 125)
Affinity DataEC50:  4.42E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240864(US9394331, 127 | US9394331, 126)
Affinity DataEC50:  274nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240864(US9394331, 127 | US9394331, 126)
Affinity DataEC50:  3.10E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240866(US9394331, 129 | US9394331, 128)
Affinity DataEC50:  450nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240866(US9394331, 129 | US9394331, 128)
Affinity DataEC50:  670nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240868(US9394331, 131 | US9394331, 130)
Affinity DataEC50:  8.65E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240868(US9394331, 131 | US9394331, 130)
Affinity DataEC50:  1.17E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240870(US9394331, 132)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240871(US9394331, 133)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240872(US9394331, 134)
Affinity DataEC50:  1.40E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240838(US9394331, 135 | US9394331, 32)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240844(US9394331, 136 | US9394331, 48)
Affinity DataEC50:  3.94E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240843(US9394331, 137 | US9394331, 49)
Affinity DataEC50: >4.53E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240839(US9394331, 138 | US9394331, 50)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240841(US9394331, 139 | US9394331, 51)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240845(US9394331, 140 | US9394331, 52)
Affinity DataEC50: >8.48E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM239045(US9408863, 1)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM239046(US9408863, 2)
Affinity DataEC50:  1.00E+4nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM239047(US9408863, 3)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM239048(US9408863, 4)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM239049(US9408863, 5)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM239050(US9408863, 6)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM239051(US9408863, 7)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM239052(US9408863, 8)
Affinity DataEC50:  3.80E+4nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 1003 total ) | Next | Last >>
Jump to: